Author Topic: Non-approved (off-label) treatments used for MS disease modification  (Read 74 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8223
  • MS diagnosed 1980
  • Location: Pacific Northwest
Cellcept (mycophonolate mofetil), Cladribine, Cytoxan (cyclophosphamide), Imuran (Azothioprine), Minocycline, Rituxan (rituximab), and statins are drugs that are prescribed off-label for MS.

The National MS Society lists them, with brief descriptions, and this list seems important enough to become a "sticky" thread, always near the top of the page:

"Non-approved treatments used for MS disease modification".
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

Offline agate

  • Administrator
  • *****
  • Posts: 8223
  • MS diagnosed 1980
  • Location: Pacific Northwest
From PubMed (August 16, 2018) this abstract of an article by researchers at Beth Israel Deaconess Medical Center in Boston  has the title "Anti-JC virus antibody index changes in rituximab-treated MS patients":


https://www.ncbi.nlm.nih.gov/pubmed/30109480
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
3 Replies
118 Views
Last post April 05, 2017, 11:15:40 am
by agate
1 Replies
75 Views
Last post June 29, 2018, 09:17:32 pm
by agate
0 Replies
43 Views
Last post July 26, 2018, 05:39:51 am
by agate
0 Replies
21 Views
Last post October 25, 2018, 10:19:36 am
by agate
0 Replies
26 Views
Last post April 01, 2019, 04:00:21 pm
by agate